equal doses of 5,000 u were administered twice daily over a period of three days and heparin activity was repeatedly controlled before and 2 , 4 , 8 hrs after injection by means of the aptt , the anti-xa clotting test and a chromogenic substrate assay .
C0019134
heparin
C0019139
anti-xa